Bioavailability of rutin and quercetin in rats  by Manach, Claudine et al.
FEBS Letters 409 (1997) 12-16 FEBS 18612 
Bioavailability of rutin and quercetin in rats 
Claudine Manacha, Christine Moranda, Christian Demignéa, Odile Texierb, 
Françoise Régératb, Christian Rémésya'* 
"Laboratoire des Maladies Métaboliques et Micronutriments, INRA de Clermont-FerrandlTheix, 63122 St. Genès-Champanelle, France 
bLaboratoire de Pharmacognosie et Biotechnologies, Faculté de Pharmacie, 63001 Clermont-Ferrand, France 
Received 6 March 1997; revised version received 30 March 1997 
Abstract Quercetin is a powerful antioxidant which is widely 
distributed in edible plants, mainly as glycosides such as rutin. It 
has been reported to be absorbed in mammals, but its metabolism 
needs further investigation to evaluate its possible physiological 
effects. We compared the evolution of the absorption of quercetin 
and rutin in rats fed with supplemented diets. Rutin was absorbed 
more slowly than quercetin because it must be hydrolysed by the 
cecal microflora, whereas quercetin was absorbed from the small 
intestine. Conjugated derivatives of quercetin, and its methylated 
forms isorhamnetin and tamarixetin, were recovered in plasma 
from rats receiving the two kinds of experimental diets after the 
first meal, but after 10 days, no traces of tamarixetin were 
detected anymore. The rate of elimination of quercetin 
metabolites seems very low, and high plasma concentrations 
are easily maintained with a regular supply of quercetin or rutin 
in the diet. 
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1. Introduction 
Flavones and flavonols are secondary metabolites of plants 
which are regularly consumed by humans. Depending on diet-
ary habits or countries, the daily intake has been estimated 
between 3 and 70 mg, essentially quercetin (60-75%) [1,2]. The 
major sources, which differ somewhat between countries, are 
tea, wine, onions, apples or berries; but fruits and vegetables 
in general also provide noticeable amounts. Flavonoids are 
non-energetic and are not considered as indispensable as are 
vitamins, yet the supply of some of them, or maybe of a 
complex mix, may have a positive effect on health. Two recent 
epidemiological studies support the view that flavones and 
flavonols protect against cardiovascular mortality [1,2]. Also, 
they have been shown to inhibit the growth of various cancer 
cell lines in vitro, and to reduce tumor development in exper-
imental animals [3]. A lot of studies have focused on the 
antioxidant effect of flavonoids, since it is now established 
that antioxidants are involved in the prevention of various 
pathologies, but their capacity to chelate metal ions or to 
influence enzymatic activities could also be involved in their 
metabolic effects [4,5]. In addition to those experiments per-
formed to determine the different effects of flavonoids on cel-
lular constituents, we need to examine their absorption and 
metabolism to evaluate their real physiological impact. 
Flavonoids usually occur as glycosides in dietary plants. 
Thus, the question arises as to whether glycosylated forms 
could be absorbed to the same extent as aglycone forms 
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from the digestive tract. It is generally considered that when 
flavonols are supplied as glycosides in the diet, they are first 
hydrolyzed by the digestive microflora before being absorbed 
[6]. However, this has been recently questioned by Hollman et 
al. [7] who reported that, in ileostomy patients, quercetin gly-
cosides from onions were more readily absorbed than the 
aglycone form. The present study was designed to compare 
the absorption of rutin and quercetin in rats, and to examine 
the influence of adaptation to a diet containing quercetin on 
its absorption and metabolism. 
2. Materials and methods 
2.1. Chemicals 
Quercetin, rutin (quercetin-3ß-D-rutinoside) and ß-glucuronidase/ 
sulfatase were purchased from Sigma (St. Louis, MO). Diosmetin, 
isorhamnetin and tamarixetin were from Extrasynthese (Genay, 
France). 
2.2. Animals and diets 
Ninety male Wistar rats (IFFA-CREDO, L'Arbresle, France) 
weighing approximately 170 g were randomly divided into three 
groups. Rats were housed, two per cage, in temperature-controlled 
rooms (22°C), with a dark period from 8:00 to 20:00 h and access 
to food from 08:00 to 16:00 h. Sixty rats called 'non-adapted rats' 
were fed semi-purified diets: a control diet for 5 days (73% wheat 
starch, 15% casein, 6% mineral mixture, 1% vitamin mixture, 5% 
corn oil), and then a single experimental meal, containing either 
0.2% quercetin or 0.4% rutin. The other 30 rats, called 'adapted 
rats' were fed the 0.2% quercetin diet for 10 days; the daily food 
intake (22.5 g/day) and weight gain (6.1 g/day) were unaffected by 
the flavonoid supplementation. Animals were maintained and handled 
according to the recommendations of the Institutional Ethic Commit-
tee (INRA), in accordance to the decree No. 87-848. 
2.3. Sampling procedure 
At 2, 4, 8, 12, and 24 h after the beginning of the experimental 
meal, 6 rats of each group were killed. They were anesthetized with 
sodium pentobarbital (40 mg/kg body weight). Blood was withdrawn 
from the portal vein (2 ml) and from the abdominal aorta (2 ml) into 
heparinized tubes. Plasmas were acidified with 10 mM acetic acid to 
prevent losses of flavonoids since the pH of plasma increases with 
time, due to decomposition of bicarbonate, and flavonoids are unsta-
ble at a pH higher than 7.4. After blood sampling, cecal contents were 
drained by finger pressure into microfuge tubes and immediately fro-
zen. 
For portal blood flow measurement, bromosulfophtalein in saline (5 
mmol/1) was infused at 50 ul/min into a mesenteric vein: dilution of 
the marker in the portal vein allows determination of the blood flow. 
2.4. HPLC analysis 
Plasmas were spiked with 25 umol/1 diosmetin, used as internal 
standard, and acidified (to pH 4.9) with 0.1 volume of 0.58 mol/1 
acetic acid solution. Solutions were treated for 30 min at 37°C in 
the presence of 5X106 units/1 ß-glucuronidase and 2.5 XlO5 units/1 
sulfatase, then treated with 8.5 volumes of acetone and centrifuged. 
Supernatants were evaporated to a volume equivalent to twice the 
initial volume of plasma. The recovery of this method has been 
checked ( > 85%o) using pure flavonoids (quercetin, diosmetin, iso-
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Fig. 1. HPLC chromatogram from a rat adapted to a quercetin diet, after enzymatic treatment to hydrolyze the conjugated metabolites. Peak 
are as follows: (1) unknown, (2) quercetin, (3) diosmetin (internal standard), (4) isorhamnetin. In inset is shown the scan of peaks 2 and 4, us-
ing a diode array detector: the spectrum of the plasma peak was compared to that of an authentic standard (smooth scan). 
rhamnetin, tamarixetin) in plasma. For analysis, 20 ul of each prep-
aration was injected onto a 150x4.6 m Hypersil BDS C18-5u column 
(Life Sciences International, Cergy, France). The mobile phase con-
sisted of 73% water/H3P04 (99.5:0.5) (solvent A) and 27% acetonitrile 
(solvent B), with flow rate 1.5 ml/min, and the UV detector was set at 
370 nm. A Beckman 168 diode array detector was also used to record 
the absorption spectra of flavonoids, and compared to authentic 
standards. 
Cecal contents were extracted with 9 volumes of acetone/HCl (50 
mM) then briefly sonicated. Supernatants were analysed with the same 
HPLC system as for plasma, but the conditions of elution were differ-
ent: with 80%i A/20% B until 2 min, then in gradient conditions to 
40% A/60% B within 8 min, next isocratically up to 12 min. These 
conditions allowed a determination of rutin (tr = 3.4 min) and quer-
cetin (tr = 8 min). 
3. Results 
Fig. 1 shows a representive chromatogram of plasma after 
enzymatic hydrolysis, from a rat adapted to a quercetm diet. 
The two major identified peaks were quercetin (Tr = 5.27 min) 
and isorhamnetin (Tr= 10.86 min). For quantification, dio-
smetin (Tr = 9.82 min) was used as internal standard. The 
inset shows the absorbance spectrum recorded on a diode 
array detector: it appears that the spectra of the sample and 
of the standard are perfectly superimposable (Similarity In-
dex: SI quercetm = 0.985, SI isorhamnetin = 0.992). In some 
samples, tamarixetin (Tr =11.45) was also detected, and it 
also displayed a high SI. In rats receiving a single experimen-
tal meal, the kinetics of intestinal absorption of rutin were 
delayed, relative to that of quercetin (Fig. 1A). 2 h after the 
beginning of the meal, a significant concentration of quercetin 
metabolites (16 ±6 (imol/1) was recorded in plasma from rats 
fed the quercetin diet. By contrast, no trace of quercetin me-
tabolites was detected at this time in the plasma from rats fed 
a rutin diet. With this diet, measurable concentrations were 
obtained only 4 h after the beginning of the meal. Later, 
plasma concentrations of quercetin metabolites were higher 
in rats fed the quercetin diet than in those fed the rutin 
diet; 24 h after the beginning of the meal, high levels were 
still present in plasma for the two types of diet (35 ±2 and 
51 ± 3 umol/1, for the rutin and quercetin group respectively). 
The absorption of quercetin was measured by arterio-ve-
nous differences (portal vein-abdominal aorta concentration) 
(Fig. IB). After the beginning of the meal, the portal blood 
flow increased progressively, from 12 ml/min at 2 h to 14 ml/ 
min at 12 h, without significant influences of the diet. During 
the early digestion period (2 h), quercetin absorption was 
detected only in rats fed the diet containing 0.2% quercetin. 
Later, in this group, the absorption flux was high (about 50 
nmol/min) and relatively constant between 4 h and 12 h after 
the beginning of the meal. In rats fed the rutin diet, the ab-
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Fig. 2. Evolution of the plasma concentration of quercetin metabo-
lites (A) and of the absorption of quercetin (B) in rats receiving a 
single meal containing 0.2% quercetin or 0.4% rutin. Values are 
means ± S.E.M. (n = 6). 
sorption flow was markedly lower than in rats fed the quer-
cetin diet, but it increased significantly between 4 and 12 h. 
Two hours after the beginning of the experimental meal, 
neither quercetin nor rutin were detected in the cecal contents 
(data not shown) ; thereafter, the rutin or quercetin which was 
not absorbed in the small intestine accumulated in the cecum. 
With the rutin diet, the two forms (rutin and quercetin) were 
recovered in the cecum (Fig. 2) but, at 4 h, the concentration 
of the aglycone was still lower than that of the glycoside. This 
was reversed from 8 h after the beginning of the meal, and at 
24 h, only quercetin could be found in the cecum. In rats fed 
the quercetin diet, quercetin accumulation was similar to the 
sum of rutin+quercetin in rats fed the rutin diet. 
In Fig. 3, the evolution of quercetin metabolites during a 24 
h period was followed in rats fed a 0.2% quercetin diet, either 
receiving it as the first experimental meal or after 10 days of 
adaptation. In non-adapted animals, there was a progressive 
accumulation of metabolites in the plasma, then a plateauing 
concentration (about 50 (a.mol/1) was observed (Fig. 3A). In 
contrast, the concentration of plasma metabolites was poorly 
affected during the digestion period in rats adapted to the 
0.2% quercetin diet. In these animals, the presence of a rela-
tively high concentration of quercetin metabolites in the plas-
ma might depress the efficiency of flavonol intestinal absorp-
tion. Thus, whatever the sampling time (4, 8 and 12 h after the 
beginning of the experimental meal), the intestinal absorption 
of quercetin was higher in non-adapted rats than in adapted 
rats (Fig. 3B). 
In the plasma from non-adapted rats, after deconjugation, 
quercetin was recovered in three forms: quercetin, 3'-0-meth-
yl derivative (isorhamnetin), 4'-0-methyl derivative (tamarix-
etin). 2 h after the beginning of the 0.2% quercetin experimen-
tal meal, quercetin was the major circulating form, then its 
level plateaued at 10-12 u.mol/1 (Fig. 4A). Also, there was a 
progressive accumulation of isorhamnetin, and at 24 h the 
isorhamnetin/quercetin ratio was about 4. The concentration 
of tamarixetin increased during the first 12 h, then it progres-
sively declined and after 24 h, this derivative was no more 
detected in plasma. Similar changes in quercetin and its meth-
yl derivative concentrations were observed with rats fed the 
0.4% rutin meal, but the magnitude of the changes was lower 
than before (Fig. 4B). In plasma from rats adapted to the 
quercetin diet, the isorhamnetin/quercetin ratio was always 
near 5, and tamarixetin was found in non-measurable concen-
trations (Fig. 5). 
4. Discussion 
The present study demonstrates noticeable differences in the 
rate of absorption and of appearance of quercetin in blood 
plasma, when provided as rutin or as quercetin. When rats 
were fed semi-purified diets containing either forms of this 
flavonol, quercetin was more rapidly absorbed than the agly-
cone moiety of rutin. Furthermore, quercetin appeared in de-
tectable amounts in the blood circulation, long before the 
bolus had reached the cecum. By contrast, in rats fed a rutin 
diet, quercetin metabolites could be found in blood plasma 
only after a significant breakdown of rutin to quercetin by the 
cecal microflora. Quercetin concentrations measured in cecal 
contents were lower in rats fed a rutin diet than in those fed a 
quercetin diet. Thus, with a quercetin diet, the possibilities of 
absorption of this flavonol appear greater than with a rutin 
diet, since quercetin is available for digestive absorption both 
in the small intestine and in the large bowel. During the post-
absorptive period, whilst absorption in the small intestine was 
declining (due to transit of digesta and dilution of remaining 
digesta by endogenous materials), flavonol absorption took 
25 
20-
15 
Ô 10 
o o 
X 
1 X & Quercetin H Rutin 
JQL 
+4H +8H +12H +24H 
Time after the beginning of the meal 
Fig. 3. Evolution of the cecal pools of rutin and quercetin in rats 
receiving a single meal containing 0.2% quercetin or 0.4% rutin. 
Values are means ± S.E.M. (n = 6). 
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Fig. 4. Evolution of the plasma concentration of quercetin metabo-
lites (A) and of the absorption of quercetin (B) in rats adapted or 
not to a 0.2% quercetin diet. Values are means ± S.E.M. (n = 6). 
place in the large intestine, and this phenomenon was ob-
served with the rutin diet as well as with the quercetin diet. 
During this period (12-24 h after the beginning of food in-
take), rutin was completely hydrolyzed to quercetin. After 24 
h, some quercetin was still present in the cecum, which sug-
gests that its absorption may spread over the total dark/light 
cycle. These data indicate that, in rats, rutin in contrast to 
quercetin, is not absorbed from the small intestine. However, 
it has recently been reported, in ileostomized subjects, that 
mono- and di-glycosyl derivatives of quercetin could also be 
absorbed by the small intestine [7]. Whether this reflects spe-
cies differences, or corresponds to modifications of the diges-
tion in ileostomized patients (for example bacterial coloniza-
tion) is still not clear. Nevertheless, in the same study, rutin 
was less effectively absorbed than quercetin. Thus it is con-
ceivable that the relatively high absorption of quercetin glyco-
sides from onions is not due to glycosylation, but rather to 
factors present in complex foodstuffs. 
Whatever the absorption site (small intestine or cecum), it 
remains to be determined whether quercetin could be trans-
ferred across digestive mucosa by a purely passive process 
(because this compound is not typically lipophilic), or by a 
carrier mediated process. There was apparently a less efficient 
absorption of quercetin in rats maintained previously on a 
flavonol diet. Thus, as with other micronutrients, the existence 
of a substantial steady state level of quercetin could lead to a 
decrease in the rate of digestive absorption. 
Previous investigations have established that : (i) about 80% 
of circulating plasma quercetin units is present as a methoxy 
derivative (isorhamnetin) and (ii) flavonol metabolites are cir-
culating in plasma as conjugated derivatives [8]. The capacities 
of flavonol biotransformations, such as catechol-O-methyl 
transferase or various transferases catalyzing sulfo- or glu-
curo-conjugations, are particularly active in the liver, which 
is considered to be the chief organ for the metabolism of 
dietary flavonols [9]. However, the existence of a conjugation 
activity in the intestinal wall could not be ruled out. In a 
previous paper, we have shown that the liver exhibits the 
capacity to O-methylate quercetin on its 4' hydroxyl (yielding 
tamarixetin), since this metabolite is found in relatively high 
concentrations in the bile [8]. In the present study, the pres-
ence of tamarixetin has been observed only in plasma from 
rats adapted to a flavonol-free diet before receiving quercetin 
in an experimental meal, whereas this compound was not 
found in plasma from rats adapted to the quercetin diet. A 
more effective release of isorhamnetin into the hepatic venous 
blood might account for its prevalence in systemic blood plas-
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Fig. 5. Evolution of the plasma concentration of quercetin metabo-
lites in rats receiving a single meal containing 0.2% quercetin (A), 
or 0.4% rutin (B), or adapted for 10 days to a 0.2% quercetin diet 
(C). Values are means ± S.E.M. (n = 6). 
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ma, but there is no satisfactory hypothesis to explain why 
tamarixetin is present only in the plasma of non-adapted 
rats. Conjugation and/or methylation, which probably play 
a role in lowering the reactivity of quercetin which arises 
from the presence of two -OH on the B-ring, or the presence 
of -OH in 3 and 5 position at the vicinity of the 4-oxo group. 
In this view, it is noteworthy that the concentration of quer-
cetin conjugates seems maximal at 20 umol/1 in rats adapted 
to a flavonol-containing diet, and at a lower value concentra-
tion in unadapted rats. Between 12 h and 24 h after the be-
ginning of the meal, slight changes in plasma quercetin me-
tabolites were observed in adapted rats; thus, elimination of 
these compounds may be compensated for by some digestive 
absorption still occurring during this period. 
The dietary level of quercetin used in the present experi-
ment (2 g/kg dry diet) is much higher than in human food, in 
which the level may be about 10-200 mg of fiavonols+fla-
vones/kg dry weight, depending on the type of plant foods 
consumed. This explains why quercetin is found in much low-
er concentrations in human plasma than in rat plasma; Holl-
man et al. [10] have found a plasma concentration of about 
0.65 umol/l quercetin after consumption of a meal containing 
150 g of fried onions (equivalent to 64 mg of pure quercetin). 
This value has been obtained after acid hydrolysis, which does 
not provide information about the concentration of the non-
conjugated form and O-methylated quercetin would not be 
detected with that procedure. 
According to Vinson et al. [11], free quercetin is one of the 
most potent antioxidant to inhibit lipid peroxidation 
(IC5os=0.22 umol/l). Thus, concentrations of 0.65 umol/1 of 
quercetin found by Hollman et al. [10] should correspond to 
an antioxidant capacity. However, quercetin is probably 
present mainly as conjugated forms, extensively bound to al-
bumin [12], and the actual antioxidant potency of these forms 
is still uncertain, and possibly lesser than that of the free 
forms. 
In conclusion, studies of the biological activity of dietary 
flavonols appear particularly complex since it is necessary to 
take into consideration a group of metabolites (phenolic acids 
arising from microbial breakdown, conjugated and methyl-
ated derivatives) instead of merely considering the free quer-
cetin form, which is probably present in very low concentra-
tions (a few nmol/1) in human plasma. Furthermore, there 
may be inter-individual variability in the metabolism of flavo-
nols, as shown previously for isoflavones [13]. 
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